Spleen participation in partial MHC class II construct neuroprotection in stroke
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Spleen participation in partial MHC class II construct neuroprotection in stroke
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-01
DOI
10.1111/cns.13369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelial Progenitor Cells Modulate Inflammation-Associated Stroke Vasculome
- (2019) Sandra A. Acosta et al. Stem Cell Reviews and Reports
- A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
- (2019) Arthur A. Vandenbark et al. Journal of Neuroinflammation
- The spleen may be an important target of stem cell therapy for stroke
- (2019) Zhe Wang et al. Journal of Neuroinflammation
- Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity
- (2019) Bei Zhang et al. CNS Neuroscience & Therapeutics
- T-Regulatory Cells Confer Increased Myelination and Stem Cell Activity after Stroke-Induced White Matter Injury
- (2019) Sydney Zarriello et al. Journal of Clinical Medicine
- Macrophages reprogram after ischemic stroke and promote efferocytosis and inflammation resolution in the mouse brain
- (2019) Wenting Zhang et al. CNS Neuroscience & Therapeutics
- Sexually dimorphic microglia and ischemic stroke
- (2019) Nadine Kerr et al. CNS Neuroscience & Therapeutics
- Brain-to-cervical lymph node signaling after stroke
- (2019) Elga Esposito et al. Nature Communications
- Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti‐inflammatory phenotype through STAT3 pathway
- (2019) Zong‐Jian Liu et al. CNS Neuroscience & Therapeutics
- A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental Stroke
- (2019) Jea-Young Lee et al. Translational Stroke Research
- Regulatory T-cells within bone marrow-derived stem cells actively confer immunomodulatory and neuroprotective effects against stroke
- (2018) Elliot G Neal et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The splenic response to stroke: from rodents to stroke subjects
- (2018) Hilary A. Seifert et al. Journal of Neuroinflammation
- PAI-1 but Not PAI-2 Gene Deficiency Attenuates Ischemic Brain Injury After Experimental Stroke
- (2018) Eva-Verena Griemert et al. Translational Stroke Research
- Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial Cells
- (2018) Kinga G. Blecharz-Lang et al. Translational Stroke Research
- Experimental ischemic stroke induces long-term T cell activation in the brain
- (2018) Luokun Xie et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Stem cell therapy for neurological disorders: A focus on aging
- (2018) Hung Nguyen et al. NEUROBIOLOGY OF DISEASE
- MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes
- (2018) Manuel Navarro-Oviedo et al. Translational Stroke Research
- Human stem cells transplanted into the rat stroke brain migrate to spleen via lymphatic and inflammation pathways
- (2018) Kaya Xu et al. HAEMATOLOGICA
- Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular construct
- (2018) Roberto Meza-Romero et al. METABOLIC BRAIN DISEASE
- Enhancing Base Excision Repair of Mitochondrial DNA to Reduce Ischemic Injury Following Reperfusion
- (2018) Roger Simon et al. Translational Stroke Research
- Sex-dependent treatment of chronic EAE with partial MHC class II constructs
- (2017) Gil Benedek et al. Journal of Neuroinflammation
- DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury
- (2017) Liu Yang et al. METABOLIC BRAIN DISEASE
- Partial MHC class II constructs as novel immunomodulatory therapy for stroke
- (2017) Gil Benedek et al. NEUROCHEMISTRY INTERNATIONAL
- Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke
- (2017) Liu Yang et al. NEUROCHEMISTRY INTERNATIONAL
- Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms
- (2017) Connor Stonesifer et al. PROGRESS IN NEUROBIOLOGY
- Chronic inflammation and apoptosis propagate in ischemic cerebellum and heart of non-human primates
- (2017) Sandra A. Acosta et al. Oncotarget
- Stroke and cardiac cell death: Two peas in a pod
- (2016) Chiara Gonzales-Portillo et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury
- (2016) Jianyi Wang et al. Translational Stroke Research
- Human megakaryocyte progenitors derived from hematopoietic stem cells of normal individuals are MHC class II-expressing professional APC that enhance Th17 and Th1/Th17 responses
- (2015) Ariel Finkielsztein et al. IMMUNOLOGY LETTERS
- Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke
- (2015) Sandra A. Acosta et al. STROKE
- Partial MHC Constructs Treat Thromboembolic Ischemic Stroke Characterized by Early Immune Expansion
- (2015) Abby L. Dotson et al. Translational Stroke Research
- HLA-DR 1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis
- (2014) R. Meza-Romero et al. JOURNAL OF IMMUNOLOGY
- Recombinant T Cell Receptor Ligand Treatment Improves Neurological Outcome in the Presence of Tissue Plasminogen Activator in Experimental Ischemic Stroke
- (2014) Wenbin Zhu et al. Translational Stroke Research
- Preclinical Evaluation of Recombinant T Cell Receptor Ligand RTL1000 as a Therapeutic Agent in Ischemic Stroke
- (2014) Wenbin Zhu et al. Translational Stroke Research
- Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects
- (2013) Gil Benedek et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke
- (2013) Gil Benedek et al. METABOLIC BRAIN DISEASE
- Ischemic Stroke Brain Sends Indirect Cell Death Signals to the Heart
- (2013) Hiroto Ishikawa et al. STROKE
- A Transient Decrease in Spleen Size Following Stroke Corresponds to Splenocyte Release into Systemic Circulation
- (2012) Hilary A. Seifert et al. Journal of Neuroimmune Pharmacology
- Comparison of Immortalized bEnd5 and Primary Mouse Brain Microvascular Endothelial Cells as in vitro Blood–Brain Barrier Models for the Study of T Cell Extravasation
- (2010) Oliver Steiner et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
- (2009) Marc Fisher et al. STROKE
- Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke
- (2008) K HARA et al. PROGRESS IN NEUROBIOLOGY
- Cell Therapy for Stroke: Remaining Issues to Address Before Embarking on Clinical Trials
- (2008) C. V. Borlongan STROKE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started